|
0
|
|
Phase 2, open-label, noncomparative clinical trial evaluating safety and efficacy of posaconazole in pediatric patients with proven/probable invasive aspergillosis or possible invasive fungal disease.
(journals.asm.org)
|
Kang HJ
…
Johnson MG
Antimicrobial Agents and Chemotherapy
2026-03-04
|
#infection
#clinical trial
#antifungal
#aspergillosis
#pediatric
|
|
0
|
|
HIV drug resistance amongst children and adolescents with viraemia in Lesotho and Tanzania: a nested analysis in the GIVE MOVE trial.
(academic.oup.com)
|
Schonenberger CM
…
Brown JA
Journal of Antimicrobial Chemotherapy
2026-03-04
|
#amr
#hiv
#adherence
#genotyping
#pediatric
|
|
0
|
|
Clinical and immunovirological status in children, adolescents and young adults with early-life-acquired HIV: a Spanish multi-cohort analysis since 2020.
(academic.oup.com)
|
Tarancon-Diez L
…
Navarro-Gomez ML
Journal of Antimicrobial Chemotherapy
2026-03-04
|
#immunity
#hiv
#pediatric
#virological
#art
|
|
0
|
|
Identification and assessment of paediatric cefepime-induced neurotoxicity in a retrospective cohort of paediatric intensive care patients.
(academic.oup.com)
|
Pavia K
…
Tang Girdwood S
Journal of Antimicrobial Chemotherapy
2026-03-04
|
#pharmacokinetics
#neurotoxicity
#antibiotic
#pediatric
#adverse drug reaction
|
|
0
|
|
Optimization strategies for voriconazole dosing in pediatric populations: integrating therapeutic indications and age-stratified pharmacokinetics.
(journals.asm.org)
|
Zhu Y
…
Huang L
Antimicrobial Agents and Chemotherapy
2026-03-04
|
#pharmacokinetics
#dosing
#metabolism
#antifungal
#pediatric
|